Sharathchandra S Hegde - Net Worth and Insider Trading

Sharathchandra S Hegde Net Worth

The estimated net worth of Sharathchandra S Hegde is at least $2 Million dollars as of 2024-11-10. Sharathchandra S Hegde is the SVP, Research of Theravance Biopharma Inc and owns about 264,444 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Details can be seen in Sharathchandra S Hegde's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sharathchandra S Hegde has not made any transactions after 2019-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sharathchandra S Hegde

To

Sharathchandra S Hegde Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sharathchandra S Hegde owns 1 companies in total, including Theravance Biopharma Inc (TBPH) .

Click here to see the complete history of Sharathchandra S Hegde’s form 4 insider trades.

Insider Ownership Summary of Sharathchandra S Hegde

Ticker Comapny Transaction Date Type of Owner
TBPH Theravance Biopharma Inc 2019-03-05 SVP & Research

Sharathchandra S Hegde Latest Holdings Summary

Sharathchandra S Hegde currently owns a total of 1 stock. Sharathchandra S Hegde owns 264,444 shares of Theravance Biopharma Inc (TBPH) as of March 5, 2019, with a value of $2 Million.

Latest Holdings of Sharathchandra S Hegde

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TBPH Theravance Biopharma Inc 2019-03-05 264,444 8.94 2,364,129

Holding Weightings of Sharathchandra S Hegde


Sharathchandra S Hegde Form 4 Trading Tracker

According to the SEC Form 4 filings, Sharathchandra S Hegde has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the sale of 9,033 shares on March 5, 2019, which brought Sharathchandra S Hegde around $223,205.

Insider Trading History of Sharathchandra S Hegde

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sharathchandra S Hegde Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sharathchandra S Hegde Ownership Network

Ownership Network List of Sharathchandra S Hegde

No Data

Ownership Network Relation of Sharathchandra S Hegde

Insider Network Chart

Sharathchandra S Hegde Owned Company Details

What does Theravance Biopharma Inc do?

Who are the key executives at Theravance Biopharma Inc?

Sharathchandra S Hegde is the SVP & Research of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .

Theravance Biopharma Inc (TBPH) Insider Trades Summary

Over the past 18 months, Sharathchandra S Hegde made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 16,734 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 0 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,963 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,471,961 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Theravance Biopharma Inc Insider Transactions

No Available Data

Sharathchandra S Hegde Mailing Address

Above is the net worth, insider trading, and ownership report for Sharathchandra S Hegde. You might contact Sharathchandra S Hegde via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.